NORTHERN TRUST CORP - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$19,975,000
+48.7%
835,773
-9.2%
0.00%
+33.3%
Q4 2020$13,434,000
-1.7%
920,200
-4.4%
0.00%0.0%
Q3 2020$13,664,000
-5.4%
962,254
-2.0%
0.00%0.0%
Q2 2020$14,446,000
+370.7%
982,089
+31.9%
0.00%
+200.0%
Q1 2020$3,069,000
-16.0%
744,808
-1.9%
0.00%0.0%
Q4 2019$3,654,000
-20.4%
759,592
+0.3%
0.00%0.0%
Q3 2019$4,588,000
+4.6%
757,206
+12.0%
0.00%0.0%
Q2 2019$4,386,000
-6.9%
675,830
+1.7%
0.00%0.0%
Q1 2019$4,710,000
+40.4%
664,300
-3.7%
0.00%0.0%
Q4 2018$3,355,000
-32.9%
690,110
+1.4%
0.00%0.0%
Q3 2018$5,001,000
+18.3%
680,325
+2.6%
0.00%0.0%
Q2 2018$4,229,000
+21.5%
662,837
+3.5%
0.00%0.0%
Q1 2018$3,482,000
+19.5%
640,145
-8.4%
0.00%0.0%
Q4 2017$2,913,000
-56.7%
698,528
-0.1%
0.00%
-50.0%
Q3 2017$6,734,000
-9.8%
699,201
+10.9%
0.00%0.0%
Q2 2017$7,462,000
+0.7%
630,760
+9.2%
0.00%0.0%
Q1 2017$7,407,000
+7.0%
577,776
+2.1%
0.00%0.0%
Q4 2016$6,925,000
+17.9%
565,742
+13.6%
0.00%0.0%
Q3 2016$5,875,000
+35.2%
497,878
-0.3%
0.00%
+100.0%
Q2 2016$4,345,000
+68.1%
499,387
+2.4%
0.00%0.0%
Q1 2016$2,585,000
-30.2%
487,617
+2.2%
0.00%0.0%
Q4 2015$3,701,000
-0.1%
476,950
+1.3%
0.00%0.0%
Q3 2015$3,706,000
-10.9%
470,904
+2.6%
0.00%0.0%
Q2 2015$4,160,000
-29.7%
459,165
+0.7%
0.00%
-50.0%
Q1 2015$5,920,000
-4.6%
456,072
+0.0%
0.00%0.0%
Q4 2014$6,205,000
+48.8%
455,979
-1.9%
0.00%
+100.0%
Q3 2014$4,170,000
-29.7%
464,874
+6.0%
0.00%
-50.0%
Q2 2014$5,935,000
+27.7%
438,630
-6.2%
0.00%
+100.0%
Q1 2014$4,647,000
-31.7%
467,569
-8.7%
0.00%
-50.0%
Q4 2013$6,803,000
+14.5%
511,847
+4.5%
0.00%0.0%
Q3 2013$5,944,000
+301.6%
489,633
+242.2%
0.00%
+100.0%
Q2 2013$1,480,000143,0690.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,500,000$25,725,0003.13%
CADIAN CAPITAL MANAGEMENT, LP 3,830,399$28,153,0001.28%
Mesirow Financial Investment Management, Inc. 33,001$243,0001.25%
Bellevue Group AG 1,339,502$9,845,0000.62%
NEEDHAM INVESTMENT MANAGEMENT LLC 260,000$1,912,0000.58%
Lyon Street Capital, LLC 109,850$807,0000.50%
Private Wealth Partners, LLC 300,000$2,205,0000.34%
Penn Capital Management Company, LLC 455,064$3,345,0000.25%
HighTower Advisors, LLC 2,337,132$17,179,0000.12%
Schonfeld Strategic Advisors LLC 376,000$2,763,0000.12%
View complete list of GENMARK DIAGNOSTICS INC shareholders